imipenem, anhydrous has been researched along with Shock, Septic in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (23.08) | 18.2507 |
| 2000's | 12 (46.15) | 29.6817 |
| 2010's | 5 (19.23) | 24.3611 |
| 2020's | 3 (11.54) | 2.80 |
| Authors | Studies |
|---|---|
| Funayama, Y; Hitomi, S; Ishikawa, H; Kiyasu, Y; Saito, K | 1 |
| Guo, F; Huang, Y; Liu, L; Liu, S; Qiu, H; Xie, J; Yang, J; Yang, Y | 1 |
| Huang, Y; Li, Q; Liu, L; Liu, S; Shao, H; Xie, J; Xu, K; Yang, Y; Zha, X; Zhan, Y | 1 |
| Gong, S; Hu, X; Jiang, Y; Li, J; Shang, X; Yu, R; Zhang, X; Zhang, Y | 1 |
| Amores Arriaga, MB; Bucar Barjud, M; Gómez del Valle, C; Josa Laorden, C; Pérez Calvo, JI; Torralba Cabeza, MA | 1 |
| Farhat, F; Narsana, N | 1 |
| Akalın, H; Heper, Y; İşçimen, R; Kahveci, F; Kelebek, N; Ocakoğlu, G; Özvatan, T; Sınırtaş, M; Yılmaz, E | 1 |
| George, GM; Ninan, J | 1 |
| Morrison, DC; Papasian, CJ; Qureshi, AA; Qureshi, N; Reis, J; Rockwell, CE; Tan, X; Vogel, SN; Yang, R | 1 |
| Chen, XG; Fu, FH; Gao, YB; Jiang, WL; Tian, JW; Zhu, HB | 1 |
| Circo, R; Cirioni, O; D'Amato, G; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G; Silvestri, C; Skerlavaj, B; Zanetti, M | 1 |
| Cirioni, O; D'Amato, G; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G; Sisti, V | 1 |
| Aissa, N; Calmette, MJ; Herve, J; Legrand, P; Renaud, B; Roupie, E; Santin, A; Sorkine, M | 1 |
| Cirioni, O; D'Amato, G; Ghiselli, R; Giacometti, A; Kamysz, W; Mocchegiani, F; Orlando, F; Rocchi, M; Saba, V; Scalise, G; Silvestri, C; Łukasiak, J | 1 |
| Benbachir, M; Benchekroun, S; Harif, M; Loukili, A; Mahmal, L; Quessar, A | 1 |
| Chien, CC; Kuo, CY; Liu, JW; Tsai, MS; Wang, MC; Wu, HC | 1 |
| Bergnach, C; Cirioni, O; Ghiselli, R; Giacometti, A; Licci, A; Mocchegiani, F; Orlando, F; Rocchi, M; Saba, V; Scalise, G; Silvestri, C; Skerlavaj, B; Zanetti, M | 1 |
| Barra, D; Bozzi, A; Cirioni, O; Di Giulio, A; Ghiselli, R; Giacometti, A; Luzi, C; Mangoni, ML; Mocchegiani, F; Orlando, F; Rinaldi, AC; Saba, V; Scalise, G; Silvestri, C | 1 |
| Fernández-Valencia, JA; García, S; Prat, S | 1 |
| March, F; Mirelis, B; Miró, E; Navarro, F; Sanchez, F | 1 |
| Drgona, L; Grausova, S; Koren, P; Krcmery, V; Krupova, I; Kukuckova, E; Kunova, A; Lacka, J; Oravcova, E; Sevcikova, L; Spanik, S; Stopkova, K; Studena, M; Svec, J; Trup, J | 1 |
| Hirai, H; Hotta, Y; Kitagawa, S; Machi, T; Matsuda, Y; Miyamori, H; Nakamura, S; Nakamura, Y; Saito, Y; Taguchi, T; Yamatani, H | 1 |
| Hatakeyama, N; Horiguchi, A; Ikeuchi, K; Oyama, M | 1 |
| Ido, A; Inoue, S; Inoue, T; Itoh, H; Kataoka, H; Koono, M; Kuwata, G; Ogata, K; Takasaki, M; Tateyama, S; Tsubouchi, H; Yamashita, K | 1 |
| Abe, K; Oishi, Y; Ueda, M; Wada, T | 1 |
| Arimoto, T; Iki, Y; Ito, K; Mochizuki, S; Nakamura, K; Niki, I; Suga, T; Yoneda, Y | 1 |
1 trial(s) available for imipenem, anhydrous and Shock, Septic
| Article | Year |
|---|---|
Comparable Effect of Two-Step Versus Extended Infusions on the Pharmacokinetics of Imipenem in Patients with Sepsis and Septic Shock.
Topics: Administration, Intravenous; Aged; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Sepsis; Shock, Septic; Treatment Outcome | 2020 |
25 other study(ies) available for imipenem, anhydrous and Shock, Septic
| Article | Year |
|---|---|
Characteristics of invasive Acinetobacter infection: A multicenter investigation with molecular identification of causative organisms.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Child; Child, Preschool; Drug Resistance, Bacterial; Female; Humans; Imipenem; Infant; Infant, Newborn; Japan; Male; Meningitis; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors; Shock, Septic; Young Adult | 2020 |
Association Between Pathophysiology and Volume of Distribution Among Patients With Sepsis or Septic Shock Treated With Imipenem: A Prospective Cohort Study.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Imipenem; Linear Models; Male; Middle Aged; Multivariate Analysis; Prognosis; Prospective Studies; Sepsis; Shock, Septic | 2020 |
Clinical Situations of Bacteriology and Prognosis in Patients with Urosepsis.
Topics: Ertapenem; Escherichia coli; Gram-Negative Bacterial Infections; Humans; Imipenem; Klebsiella pneumoniae; Quinolones; Sepsis; Shock, Septic; Urinary Tract Infections | 2019 |
Septic shock due to Rhodococcus equi in a patient with chronic myelomonocytic leukemia.
Topics: Actinomycetales Infections; Aged; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Diagnosis, Differential; Drug Therapy, Combination; Fertilizers; Humans; Imipenem; Immunocompromised Host; Leukemia, Myelomonocytic, Chronic; Lung Abscess; Lung Neoplasms; Male; Manure; Opportunistic Infections; Rhodococcus equi; Rifampin; Shock, Septic; Tomography, X-Ray Computed | 2013 |
Septic shock due to Pasteurella multocida bacteremia: a case report.
Topics: Aged, 80 and over; Animals; Anti-Bacterial Agents; Bites and Stings; Cats; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Pasteurella Infections; Pasteurella multocida; Shock, Septic | 2015 |
Nosocomial Acinetobacter pneumonia: Treatment and prognostic factors in 356 cases.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Prognosis; Retrospective Studies; Risk Factors; Severity of Illness Index; Shock, Septic | 2016 |
Imipenem-cilastatin-induced psychosis: a case report.
Topics: Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Humans; Imipenem; Male; Middle Aged; Psychoses, Substance-Induced; Shock, Septic; Urinary Tract Infections | 2016 |
A combination of proteasome inhibitors and antibiotics prevents lethality in a septic shock model.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Cell Death; Cell Line; Cysteine Proteinase Inhibitors; Disease Models, Animal; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imipenem; Lipopolysaccharides; Lovastatin; Macrophages; Mice; Nitric Oxide; Proteasome Inhibitors; Quercetin; Shock, Septic; Tumor Necrosis Factor-alpha | 2008 |
Paeoniflorin inhibits systemic inflammation and improves survival in experimental sepsis.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzoates; Blood Urea Nitrogen; Bridged-Ring Compounds; Cecum; Cell Line; Clinical Enzyme Tests; DNA-Binding Proteins; Endotoxins; Glucosides; Hemodynamics; Imipenem; Inflammation; Inflammation Mediators; Intestine, Small; Lactic Acid; Liver; Lung; Macrophages; Male; Membrane Glycoproteins; Mice; Monoterpenes; Peroxidase; Rats; Rats, Sprague-Dawley; Receptors, Immunologic; Shock, Septic; Triggering Receptor Expressed on Myeloid Cells-1 | 2009 |
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock.
Topics: Animals; Anti-Bacterial Agents; Blood Proteins; Cathelicidins; Escherichia coli; Imipenem; In Vitro Techniques; Limulus Test; Lipopolysaccharides; Male; Polymyxin B; Rats; Rats, Wistar; Sheep; Shock, Septic | 2004 |
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Drug Synergism; Drug Therapy, Combination; Endotoxins; Escherichia coli; Escherichia coli Infections; Imipenem; Injections, Intraperitoneal; Insect Proteins; Lipopolysaccharides; Male; Piperacillin; Rats; Rats, Wistar; Shock, Septic | 2004 |
Campylobacter fetus meningitis in a diabetic adult cured by imipenem.
Topics: Aged; Campylobacter fetus; Campylobacter Infections; Critical Illness; Diabetes Mellitus, Type 2; Emergency Service, Hospital; Follow-Up Studies; Humans; Imipenem; Infusions, Intravenous; Male; Meningitis, Bacterial; Risk Assessment; Shock, Septic; Treatment Outcome | 2004 |
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cecum; Drug Therapy, Combination; Endotoxins; Escherichia coli; Escherichia coli Infections; Imipenem; Injections, Intraperitoneal; Limulus Test; Lipopolysaccharides; Male; Piperacillin; Polymyxin B; Rats; Rats, Wistar; Shock, Septic; Time Factors; Tumor Necrosis Factor-alpha | 2005 |
[Germs that produce the extended spectrum betalactamases].
Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Emergencies; Escherichia coli; Escherichia coli Infections; Female; Hospitals, University; Humans; Imipenem; Leukemia; Lymphoma, Non-Hodgkin; Male; Morocco; Neutropenia; Retrospective Studies; Shock, Septic; Time Factors | 2004 |
Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies.
Topics: Aeromonas; Aged; Aged, 80 and over; Antineoplastic Agents; Bacteremia; Consciousness Disorders; Drug Resistance, Bacterial; Female; Fever; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Hospitals; Humans; Imipenem; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Piperacillin; Prognosis; Risk Factors; Shock, Septic; Taiwan; Time Factors | 2006 |
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cathelicidins; Cecum; Disease Models, Animal; Endotoxins; Escherichia coli; Escherichia coli Infections; Gram-Negative Bacteria; Imipenem; Injections, Intraperitoneal; Male; Nitrites; Piperacillin; Polymyxin B; Random Allocation; Rats; Rats, Wistar; Serotyping; Shock, Septic; Tumor Necrosis Factor-alpha | 2006 |
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria.
Topics: Animals; Anti-Infective Agents; Antimicrobial Cationic Peptides; beta-Lactams; Disease Models, Animal; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Lipopolysaccharides; Male; Microbial Sensitivity Tests; Peritonitis; Piperacillin; Proteins; Rats; Rats, Wistar; Shock, Septic | 2006 |
Pasteurella multocida septic shock after a cat scratch in an elderly otherwise healthy woman: a case report.
Topics: Aged; Animals; Anti-Bacterial Agents; Cats; Diagnosis, Differential; Female; Humans; Imipenem; Magnetic Resonance Imaging; Pasteurella Infections; Pasteurella multocida; Shock, Septic; Shoulder | 2008 |
Emergence of different resistance mechanisms in Pseudomonas aeruginosa in a patient treated with imipenem.
Topics: Anti-Infective Agents; beta-Lactam Resistance; Ciprofloxacin; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Shock, Septic; Thienamycins | 1995 |
Imipenen-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome.
Topics: Adult; Bacteremia; Cancer Care Facilities; Drug Resistance, Microbial; Humans; Imipenem; Incidence; Neoplasms; Pseudomonas Infections; Risk Factors; Shock, Septic; Slovakia; Thienamycins | 1996 |
[Case of streptococcal toxic shock-like syndrome].
Topics: Aged; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Clindamycin; Drug Combinations; Drug Therapy, Combination; Female; Hemofiltration; Humans; Imipenem; Shock, Septic; Streptococcal Infections; Streptococcus pyogenes | 1997 |
[A case of septic shock following incarceration of the penis].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Escherichia coli Infections; gamma-Globulins; Humans; Imipenem; Male; Methylprednisolone; Minocycline; Penis; Shock, Septic | 1998 |
Aeromonas sobria infection with severe soft tissue damage and segmental necrotizing gastroenteritis in a patient with alcoholic liver cirrhosis.
Topics: Aeromonas; Dopamine; Enterocolitis, Necrotizing; Fatal Outcome; Gastroenteritis; Gram-Negative Bacterial Infections; Humans; Imipenem; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Minocycline; Multiple Organ Failure; Norepinephrine; Shock, Septic; Soft Tissue Infections | 1999 |
[A case of effective endotoxin adsorption therapy for septic shock due to acute pyelonephritis].
Topics: Acute Disease; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Endotoxins; Escherichia coli; Escherichia coli Infections; Hemofiltration; Humans; Imipenem; Male; Middle Aged; Pyelonephritis; Shock, Septic; Sorption Detoxification; Treatment Outcome; Ureteral Calculi | 2000 |
[A case of salmonella colitis complicated with delirium, disseminated intravascular coagulation and multiple organ failure].
Topics: Adult; Chloramphenicol; Colitis; Delirium; Disseminated Intravascular Coagulation; Humans; Imipenem; Male; Multiple Organ Failure; Salmonella Infections; Salmonella typhimurium; Shock, Septic | 1990 |